We have developed a new protein-protein interaction (PPI) small molecule inhibitor drug discovery platform.
APG has received an EU grant by the PERMIDES initiative to establish an in silico drug discory platform.
We have currently two drug discovery programs:
Huntington's disease and a transcription factor inhibitor for cancer treatment.
COPYRIGHT © 2014 | ALL RIGHTS RESERVED
PRIVACY STATEMENT | TERMS & CONDITIONS